Advertisement Lilly makes senior management changes - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lilly makes senior management changes

Eli Lilly and Company has announced that Alex Azar II, currently senior vice president of corporate affairs and communications, will assume the top leadership role in the company's US business-to-business organization.

As vice president of business-to-business and Puerto Rico, Mr Azar will oversee the company’s public payer, managed care and wholesaler operations in the US as well as oversee Lilly’s sales and marketing operations in Puerto Rico.

Mr Azar joined Lilly in 2007 and, during his tenure leading Lilly’s corporate affairs function, helped position Lilly as a leading advocate of public policies that support biopharmaceuticals and advocated for healthcare reform that would improve efficiency, choice and access for patients, the company said.

In a related move, Jack Bailey, US senior vice president of account-based markets, will broaden his leadership responsibilities to include oversight of the US diabetes business unit. This adds to his current responsibilities for Lilly USA’s oncology and cardiovascular teams, as well as the Lilly Hospital Group.

Mr Bailey joined Lilly in 1991. During his 18-year tenure at the company, he has held positions in sales and marketing and business development. In 1998, he assumed the role of general manager for Lilly’s affiliate in South Africa and also directed regional sales operations across sub-Saharan Africa. In 2001, he returned to the US to lead Lilly’s business-to-business organization.

Mr Azar and Mr Bailey will fully assume their new responsibilities on April 1, 2009.